IP Library Granted Patent US 8,828,043
Granted Patent B2
US 8,828,043 · App. 13/157,903 · Granted Sep 9, 2014

Systems and methods for preventing formation of blood clots in the left atrium

Inventor: Jeffrey W. Chambers (Maple Grove, MN)
A61F2/2487A61B17/12122A61B17/12168A61F2250/0067
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,828,043
App. No.
13/157,903
Granted
Sep 9, 2014
Kind
B2
Abstract

An implantable liner device for preventing formation of blood clots in a left atrium of a patient's heart. The liner device includes a liner body configured, in some embodiments, to cover a portion of an interior surface of the left atrium, the liner body forming a first opening sized for placement about pulmonary vein ostiums of the left atrium and a second opening for fluid alignment with a mitral valve of the left atrium. The liner body can self-expandable from a collapsed state appropriate for percutaneous delivery to the atrium to an expanded state, with the expanded state having a shape appropriate for covering the portion of the interior surface of the left atrium. The liner body can have a cap-like shape, and can be formed of mesh, fabric, braided material, and biological material such as tissue.

Claims (11)

1. An implantable liner device for preventing formation of blood clots in a left atrium of a patient's heart, the device comprising:

a liner body configured to cover a portion of an interior surface of the left atrium, the liner body having a cup shape defining a closed proximal end and forming a first opening configured for placement about pulmonary vein ostiums of the left atrium and a second opening for fluid alignment with a mitral valve of the left atrium, the first opening being formed through a thickness of the liner body between the closed proximal end and the second opening, wherein the liner device is configured to maintain an expandable outward force against interior walls of the left atrium.

2. The liner device of claim 1 , wherein the liner body is configured to self-transition from a collapsed state to an expanded state, the expanded state shaped to cover a portion of an interior surface of the left atrium.

3. The liner device of claim 2 , wherein the liner body has the cup shape in the expanded state.

4. The liner device of claim 1 , wherein the liner body is formed of a polymer.

5. The liner device of claim 1 , wherein the liner body is formed of a metal mesh.

6. The liner device of claim 1 , wherein the liner body is formed of a braided material.

7. The liner device of claim 1 , wherein the liner body includes biological material.

8. The liner device of claim 1 , wherein the liner body is configured to be implanted percutaneously.

9. The liner device of claim 1 , wherein the second opening is formed at a distal end of the liner body opposite the closed proximal end.

10. The liner device of claim 1 , wherein the liner body is configured to match a size, shape and contour of the interior surface of the left atrium.

Continuity (2)
Provisional Application 61353466 · Jun 10, 2010
Related Publication 20110307003A1 · Dec 15, 2011